Esketamine-lidocaine group
2023-451-2
Unknown small_molecule active
Quick answer
Esketamine-lidocaine group for Postoperative Chronic Pain is a Unknown program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Postoperative Chronic Pain
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active